Role of growth hormone in hepatic and intestinal triglyceride-rich lipoprotein metabolism - Archive ouverte HAL Access content directly
Journal Articles Journal of clinical lipidology Year : 2021

Role of growth hormone in hepatic and intestinal triglyceride-rich lipoprotein metabolism

(1, 2) , (1, 2) , (3) , (4, 2, 5) , (6, 7, 8) , (1, 2) , (1, 2) , (9) , (4, 2, 5) , (4, 2, 5) , (1, 2) , (2) , (4, 2, 5) , (1, 2) , (1, 2)
1
2
3
4
5
6
7
8
9

Abstract

Background: Elevated plasma concentrations of hepatic- and intestinally-derived triglyceride-rich lipoproteins (TRL) are implicated in the pathogenesis of atherosclerotic cardiovascular disease and all-cause mortality. Excess of TRL is the driving cause of atherogenic dyslipidemia commonly occurring in insulin-resistant individuals such as patients with obesity, type 2 diabetes and metabolic syndrome. Interestingly, growth hormone (GH)-deficient individuals display similar atherogenic dyslipidemia, suggesting an important role of GH and GH deficiency in the regulation of TRL metabolism. Objective: We aimed to examine the direct and/or indirect role of GH on TRL metabolism. Methods: We investigated the effect on fasting and postprandial hepatic-TRL and intestinal-TRL metabolism of short-term (one month) withdrawal of GH in 10 GH-deficient adults. Results: After GH withdrawal, we found a reduction in fasting plasma TRL concentration (significant decrease in TRL-TG, TRL-cholesterol, TRL-apoB-100, TRL-apoC-III and TRL-apoC-II) but not in postprandial TRL response. This reduction was due to fewer fasting TRL particles without a change in TG per particle and was not accompanied by a change in postprandial TRL-apoB-48 response. Individual reductions in TRL correlated strongly with increases in insulin sensitivity and decreases in TRL-apoC-III. Conclusion: In this relatively short term 'loss of function' human experimental model, we have shown an unanticipated reduction of hepatic-TRL particles despite increase in total body fat mass and reduction in lean mass. These findings contrast with the atherogenic dyslipidemia previously described in chronic GH deficient states, providing a new perspective for the role of GH in lipoprotein metabolism.
Embargoed file
Embargoed file
Ne sera jamais visible

Dates and versions

inserm-03462002 , version 1 (01-12-2021)

Identifiers

Cite

Marie Maraninchi, Anastasia Calabrese, Juan-Patricio Nogueira, Frédéric Castinetti, Julien Mancini, et al.. Role of growth hormone in hepatic and intestinal triglyceride-rich lipoprotein metabolism. Journal of clinical lipidology, 2021, S1933-2874 (21), pp.00123-9. ⟨10.1016/j.jacl.2021.08.003⟩. ⟨inserm-03462002⟩
23 View
13 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More